Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community

被引:322
作者
Boeger, Rainer H. [1 ]
Sullivan, Lisa M. [2 ,3 ]
Schwedhelm, Edzard [1 ]
Wang, Thomas J. [2 ,5 ]
Maas, Renke [1 ]
Benjamin, Emelia J. [2 ,4 ]
Schulze, Friedrich [1 ]
Xanthakis, Vanessa [2 ,3 ]
Benndorf, Ralf A. [1 ]
Vasan, Ramachandran S. [2 ,4 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Inst Expt & Clin Pharmacol, Clin Pharmacol Unit, Hamburg, Germany
[2] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA
[3] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA
[4] Boston Univ, Sch Publ Hlth, Div Cardiol, Boston, MA USA
[5] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA
基金
美国国家卫生研究院;
关键词
cardiovascular diseases; epidemiology; nitric oxide; population; risk factors; GLOMERULAR-FILTRATION-RATE; CORONARY-HEART-DISEASE; NITRIC-OXIDE SYNTHESIS; MYOCARDIAL-INFARCTION; RISK; SYNTHASE; ARGININE; EVENTS; ADMA; DYSFUNCTION;
D O I
10.1161/CIRCULATIONAHA.108.838268
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, induces endothelial dysfunction. Although elevated ADMA has been associated with an increased risk of cardiovascular disease events and death in referral samples, the prognostic significance of ADMA in the community has not been adequately evaluated. Methods and Results-We related plasma ADMA, L-arginine (Arg), and the ratio of Arg to ADMA to the incidence of cardiovascular disease (fatal or nonfatal myocardial infarction, coronary insufficiency, angina pectoris, stroke or transient ischemic attack, intermittent claudication, or heart failure) and death in 3320 Framingham Offspring Study participants (1769 women; mean age, 59 years). Over a follow-up period of 10.9 years, 281 individuals of 2956 free of cardiovascular disease at baseline developed incident cardiovascular disease, and 285 participants died. In multivariable models adjusting for established risk factors and other biomarkers (B-type natriuretic peptide, renin, homocysteine, urine albumin excretion, and C-reactive protein), ADMA and the ratio of Arg to ADMA were significantly associated with all-cause mortality (adjusted-hazard ratio [HR] per 1-SD increment, 1.21; 95% CI, 1.07 to 1.37; and HR per 1-SD increment, 0.80; 95% CI, 0.69 to 0.93, respectively), whereas Arg was not (HR per 1-SD increment, 0.89; 95% CI, 0.77 to 1.02). We noted effect modification by diabetes status; ADMA was associated with death in individuals without diabetes (adjusted HR per 1-SD increment, 1.30; 95% CI, 1.13 to 1.50) but not in individuals with diabetes (adjusted HR per 1-SD increment, 0.85; 95% CI, 0.62 to 1.16). ADMA, Arg, and the ratio of Arg to ADMA were not associated with cardiovascular disease incidence (P > 0.10). Conclusions-In our large community-based sample, ADMA was significantly associated with all-cause mortality, particularly in nondiabetic individuals. ( Circulation. 2009; 119: 1592-1600.)
引用
收藏
页码:1592 / U65
页数:13
相关论文
共 41 条
[11]   Janus-faced role of endothelial NO synthase in vascular disease:: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal [J].
Foerstermann, Ulrich .
BIOLOGICAL CHEMISTRY, 2006, 387 (12) :1521-1533
[12]   Oxidative stress and diabetic cardiovascular complications [J].
Jay, D ;
Hitomi, H ;
Griendling, KK .
FREE RADICAL BIOLOGY AND MEDICINE, 2006, 40 (02) :183-192
[13]  
Kannel W.B., 1987, SOME RISK FACTORS RE
[14]   INVESTIGATION OF CORONARY HEART-DISEASE IN FAMILIES - FRAMINGHAM OFFSPRING STUDY [J].
KANNEL, WB ;
FEINLEIB, M ;
MCNAMARA, PM ;
GARRISON, RJ ;
CASTELLI, WP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1979, 110 (03) :281-290
[15]   Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans [J].
Kielstein, JT ;
Impraim, B ;
Simmel, S ;
Bode-Böger, SM ;
Tsikas, D ;
Frölich, JC ;
Hoeper, MM ;
Haller, H ;
Fliser, D .
CIRCULATION, 2004, 109 (02) :172-177
[16]   Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events [J].
Krempl, TK ;
Maas, R ;
Sydow, K ;
Meinertz, T ;
Böger, RH ;
Kähler, J .
EUROPEAN HEART JOURNAL, 2005, 26 (18) :1846-1851
[17]   Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with Type 2 diabetes and albuminuria [J].
Krzyzanowska, K. ;
Mittermayer, F. ;
Shnawa, N. ;
Hofer, M. ;
Schnabler, J. ;
Etmueller, Y. ;
Kapiotis, S. ;
Wolzt, M. ;
Schernthaner, G. .
DIABETIC MEDICINE, 2007, 24 (01) :81-86
[18]   Disruption of methylarginine metabolism impairs vascular homeostasis [J].
Leiper, James ;
Nandi, Manasi ;
Torondel, Belen ;
Murray-Rust, Judith ;
Malaki, Mohammed ;
O'Hara, Bernard ;
Rossiter, Sharon ;
Anthony, Shelagh ;
Madhani, Melanie ;
Selwood, David ;
Smith, Caroline ;
Wojciak-Stothard, Beata ;
Rudiger, Alain ;
Stidwill, Ray ;
McDonald, Neil Q. ;
Vallance, Patrick .
NATURE MEDICINE, 2007, 13 (02) :198-203
[19]   Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women - 24-year follow-up of the population study of women in Gothenburg [J].
Leong, Tora ;
Zylberstein, Dimitri ;
Graham, Ian ;
Lissner, Lauren ;
Ward, Deirdre ;
Fogarty, Jane ;
Bengtsson, Calle ;
Bjoerkelund, Cecilia ;
Thelle, Dag .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (05) :961-967
[20]   A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation [J].
Levey, AS ;
Bosch, JP ;
Lewis, JB ;
Greene, T ;
Rogers, N ;
Roth, D .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (06) :461-+